Current Neuro-Oncology
Volume
23 Number 15
15 August 2021
Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 15, 15 August
Aljabab
S, Rana S, Maes S, O'Ryan-Blair A, Castro J, Zheng J, Halasz LM,
Taddei PJ.
The
Advantage of Proton Therapy in Hypothalamic-Pituitary Axis and
Hippocampus
Avoidance for Children with Medulloblastoma.
Int
J Part Ther. 2021 Aug 2, 2021;8(3):43-54∟.
doi: 10.14338/IJPT-21-00001.1∟.
PMID: 35127975∟.
Observational study. ˍ
Ceravolo
I, Barchetti G, Biraschi F, Gerace C, Pampana E, Pingi A, Stasolla
A.
Early
stage glioblastoma: retrospective multicentric analysis of
clinical and radiological features.
Radiol
Med. 2021 Aug 2, 2021;126(11):1468-1476∟.
doi: 10.1007/s11547-021-01401-4∟.
PMID: 34338949∟.
Observational study˰ ˍ
Banan
R, Akbarian A, Samii M, Samii A, Bertalanffy H, Lehmann U,
Hartmann C, Brüning R.
Diffuse
midline gliomas, H3 K27M-mutant are associated with less
peritumoral edema and contrast enhancement in comparison to
glioblastomas, H3 K27M-wildtype of midline structures.
PLoS
One. 2021 Aug 4, 2021;16(8):e0249647∟.
doi: 10.1371/journal.pone.0249647∟.
PMID: 34347774∟.
Observational study. ˍ
Mizumoto
M, Liang HK, Oshiro Y, Matsuda M, Kohzuki H, Iizumi T, Numajiri H,
Nakai K, Okumura T, Ishikawa E, Sakurai H.
Radiation
Therapy for Grade 3 Gliomas: Correlation of MRI Findings With
Prognosis.
Cureus.
2021 Aug 4, 2021;13(8):e16887∟.
doi: 10.7759/cureus.16887∟.
PMID: 34513462∟.
Observational study. ˍ
Su
JM, Kilburn LB, Mansur DB, Krailo M, Buxton A, Adekunle A, Gajjar
A, Adamson PC, Weigel B, Fox E, Blaney SM, Fouladi M.
Phase
I/II trial of vorinostat and radiation and maintenance vorinostat
in children with diffuse intrinsic pontine glioma: A Children's
Oncology Group report.
Neuro
Oncol. 2021 Aug 4, 2022 Apr;24(4):655-664∟.
doi: 10.1093/neuonc/noab188∟.
PMID: 34347089∟.
Interventional study. ˍ
Bagchi
A, Beddows I, Cornelius A, Robinson GW, Jewell SD.
Rare
cases of medulloblastoma with hypermutation.
Cancer
Rep (Hoboken). 2021 Aug 5, 2022;5(5):e1521∟.
doi: 10.1002/cnr2.1521∟.
PMID: 34351088∟.
Observational study. ˍ
Mansfield
AS, Hong DS, Hann CL, Farago AF, Beltran H, Waqar SN, Hendifar AE,
Anthony LB, Taylor MH, Bryce AH, Tagawa ST, Lewis K, Niu J, Chung
CH, Cleary JM, Rossi M, Ludwig C, Valenzuela R, Luo Y, Aggarwal
R.
A
phase I/II study of rovalpituzumab tesirine in delta-like
3-expressing advanced solid tumors.
NPJ
Precis Oncol. 2021 Aug 5, 2021;5(1):74∟.
doi: 10.1038/s41698-021-00214-y∟.
PMID: 34354225∟.
Interventional
study.
ˍ
Volpe
S, Bondiau PY, Claude L, Claren A, Padovani L, AlGhamdi H, Duhil
De Benaze G, Opitz L, Baudin G, Dejean C, Maneval D,
Jereczek-Fossa BA, Doyen J.
Postsurgical
geometrical variations of tumor bed and brainstem during photon
and proton therapy for pediatric tumors of the posterior fossa:
dosimetric impact and predictive factors.
Strahlenther
Onkol. 2021 Aug 5, 2021;197(12):1113-1123∟.
doi: 10.1007/s00066-021-01828-8∟.
PMID: 34351450∟.
Observational study. ˍ
McCrea
HJ, Ivanidze J, O'Connor A, Hersh EH, Boockvar JA, Gobin YP,
Knopman J, Greenfield JP.
Intraarterial
delivery of bevacizumab and cetuximab utilizing blood-brain
barrier disruption in children with high-grade glioma and diffuse
intrinsic pontine glioma: results of a phase I trial.
J
Neurosurg Pediatr. 2021 Aug 6, 2021;28(4):371-379∟.
doi: 10.3171/2021.3.PEDS20738∟.
PMID: 34359048∟.
Interventional
study.
ˍ
Fernández-de
Thomas RJ, Pellot Cestero JE, Carballo Cuello CM, De Jesus
O.
Unusual
extracranial spread of glioblastoma.
BMJ
Case Rep. 2021 Aug 10, 2021;14(8):e243909∟.
doi: 10.1136/bcr-2021-243909∟.
PMID: 34376419∟.
Case report. ˍ
Lombardi
G, Del Bianco P, Brandes AA, Eoli M, Rudà R, Ibrahim T,
Lolli I, Rizzato S, Daniele B, Pace A, Pasqualetti F, Caccesse M,
Bergo E, Magni G, De Salvo GL, Zagonel V.
Patient-reported
outcomes in a phase II randomised study of regorafenib compared
with lomustine in patients with relapsed glioblastoma (the REGOMA
trial).
Eur
J Cancer. 2021 Aug 10, 2021;155:179-190∟.
doi: 10.1016/j.ejca.2021.06.055∟.
PMID: 34388515∟.
Interventional
study. ˍ
*
Jena
A, Taneja S, Khan AA, Sogani SK.
Recurrent
Glioma: Does Qualitative Simultaneous 18F-DOPA PET/mp-MRI Improve
Diagnostic Workup? An Initial Experience.
Clin
Nucl Med. 2021 Aug 11, 2021;46(9):703-709∟.
doi: 10.1097/RLU.0000000000003728∟.
PMID: 34374678∟.
Observational study˰ ˍ
Annavarapu
S, Gogate A, Pham T, Davies K, Singh P, Robert N.
Treatment
patterns and outcomes for patients with newly diagnosed
glioblastoma multiforme: a retrospective cohort study.
CNS
Oncol. 2021 Aug 11, 2021;10(3):CNS76∟.
doi: 10.2217/cns-2021-0007∟.
PMID: 34378977∟.
Observational study. ˍ
Jo
J, Donahue J, Sarai G, Petroni G, Schiff D.
Management
of venous thromboembolism in high-grade glioma: Does low molecular
weight heparin increase intracranial bleeding risk?
Neuro
Oncol. 2021 Aug 12, 2022;24(3):455-464∟.
doi: 10.1093/neuonc/noab198∟.
PMID: 34383073∟.
Observational study. ˍ
Sagberg
LM, Jakola AS, Reinertsen I, Solheim O.
How
well do neurosurgeons predict survival in patients with high-grade
glioma?
Neurosurg
Rev. 2021 Aug 12, 2022;45(1):865-872∟.
doi: 10.1007/s10143-021-01613-2∟.
PMID: 34382108∟.
Interventional study. ˍ
Li
C, Li W, Dai S, Sharma A, Sharma HS, Wu Y.
Targeted
therapy with anlotinib for a leptomeningeal spread recurrent
glioblastoma patient.
Prog
Brain Res. 2021 Aug 13, 2021;265:407-414∟.
doi: 10.1016/bs.pbr.2021.06.018∟.
PMID: 34560927∟.
Case report˰ ˍ
Yuan
C, Yao Q, Cheng L, Zhang C, Ma L, Guan J, Jian F.
Prognostic
factors and nomogram prediction of survival probability in primary
spinal cord astrocytoma patients.
J
Neurosurg Spine. 2021 Aug 13:1-12∟.
doi: 10.3171/2021.1.SPINE202017∟.
PMID: 34388706∟.
Observational study. ˍ
*
Wang
GM, Cioffi G, Patil N, Waite KA, Lanese R, Ostrom Q, Kruchko C,
Berens ME, Connor JR, Lathia JD, Rubin JB, Barnholtz-Sloan
JS.
Importance
of the
intersection
of age and sex to understand variation in incidence and survival
for
primary malignant gliomas.
Neuro
Oncol. 2021 Aug 13, 2022;24(2):302-310∟.
doi: 10.1093/neuonc/noab199∟.
PMID: 34387331∟.
Observational study. ˍ
Quinones
MC, Bélanger K, Lemieux Blanchard É, Lemieux B,
Bahary JP, Masucci LG, Roberge D, Menard C, Lambert C, Berthelet
F, Moumdjian R, Florescu M.
Adult
Medulloblastoma Demographic, Tumor and Treatment Impact since
2006: A Canadian University Experience.
Curr
Oncol. 2021 Aug 14, 2021;28(4):3104-3114∟.
doi: 10.3390/curroncol28040271∟.
PMID: 34436037∟.
Observational study. ˍ